Position in GRAL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$24,099
+$8,234 QoQ
Shares Held
353
+15.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#249
of 371 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Kemnay Advisory Services Inc. holds $29,617,086 across 14 Diagnostics & Research names. GRAL ranks #5 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
37,955 | $19,029,118 | |
| 2 | DHR |
Danaher Corp /De/
|
54,382 | $10,358,683 | |
| 3 | TWST |
Twist Bioscience Corp
|
549 | $56,481 | |
| 4 | VCYT |
Veracyte, Inc.
|
711 | $41,757 | |
| 5 | GRAL |
GRAIL, Inc.
This page
|
353 | $24,099 | |
| 6 | RDNT |
RadNet, Inc.
|
318 | $19,611 | |
| 7 | GH |
Guardant Health, Inc.
|
116 | $17,403 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
33 | $17,372 |
All Filings in GRAL
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,099 | 353 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $15,865 | 307 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,189 | 84 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||